PSTO 16: IMPAACT 2017 - Phase I/II Study of the Safety, Acceptability, Tolerability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Long-Acting Injectable Rilpivirine in Virologically Suppressed HIV-Infected Children and Adolesce

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/19 → 12/30/22

Funding

  • Johns Hopkins University (2004132092)
  • ViiV Healthcare (2004132092)